226 related articles for article (PubMed ID: 36729305)
1. Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis.
Song MK; Park SI; Cho SW
J Bone Miner Metab; 2023 May; 41(3):337-344. PubMed ID: 36729305
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Markers of bone turnover in bone metastases.
Fontana A; Delmas PD
Cancer; 2000 Jun; 88(12 Suppl):2952-60. PubMed ID: 10898339
[TBL] [Abstract][Full Text] [Related]
4. Bone metabolic markers as gauges of metastasis to bone: a review.
Koizumi M; Ogata E
Ann Nucl Med; 2002 May; 16(3):161-8. PubMed ID: 12126040
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
6. Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone.
Wu SL; Jones E; Gulley JL; Arlen PM; Chen CC; Figg WD; Dahut WL
BJU Int; 2007 Mar; 99(3):525-8. PubMed ID: 17155971
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
[TBL] [Abstract][Full Text] [Related]
8. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
Wada Y; Anbai A; Kumagai S; Okuyama E; Hatakeyama K; Takagi N; Hashimoto M
Radiat Oncol; 2019 Jun; 14(1):98. PubMed ID: 31174548
[TBL] [Abstract][Full Text] [Related]
9. Computerized Tomography (CT) Updates and Challenges in Diagnosis of Bone Metastases During Prostate Cancer.
Zhang J; Zhai G; Yang B; Liu Z
Curr Med Imaging; 2020; 16(5):565-571. PubMed ID: 32484090
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
[TBL] [Abstract][Full Text] [Related]
11. The Established Nuclear Medicine Modalities for Imaging of Bone Metastases.
Jabeen N; Rasheed R; Rafique A; Murtaza G
Curr Med Imaging Rev; 2019; 15(9):819-830. PubMed ID: 32008530
[TBL] [Abstract][Full Text] [Related]
12. Use of markers of bone turnover for monitoring bone metastases and the response to therapy.
Lipton A; Costa L; Ali S; Demers L
Semin Oncol; 2001 Aug; 28(4 Suppl 11):54-9. PubMed ID: 11544577
[TBL] [Abstract][Full Text] [Related]
13. Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model.
Missbach-Guentner J; Dullin C; Zientkowska M; Domeyer-Missbach M; Kimmina S; Obenauer S; Kauer F; Stühmer W; Grabbe E; Vogel WF; Alves F
Neoplasia; 2007 Sep; 9(9):755-65. PubMed ID: 17898871
[TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison of
Zhang Y; Lin Z; Li T; Wei Y; Yu M; Ye L; Cai Y; Yang S; Zhang Y; Shi Y; Chen W
Sci Rep; 2022 Sep; 12(1):15993. PubMed ID: 36163353
[TBL] [Abstract][Full Text] [Related]
15. Radiologic diagnosis of bone metastases.
Rosenthal DI
Cancer; 1997 Oct; 80(8 Suppl):1595-607. PubMed ID: 9362427
[TBL] [Abstract][Full Text] [Related]
16. Application of Diffusion Weighted Imaging in Prostate Cancer Bone Metastasis: Detection and Therapy Evaluation.
Gong XQ; Tao YY; Wang R; Liu N; Huang XH; Zheng J; Yang C; Yang L; Zhang XM
Anticancer Agents Med Chem; 2021; 21(15):1950-1956. PubMed ID: 33461473
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable?
Morris MJ; Autio KA; Basch EM; Danila DC; Larson S; Scher HI
Semin Oncol; 2013 Jun; 40(3):375-92. PubMed ID: 23806501
[TBL] [Abstract][Full Text] [Related]
18. Animal models of bone metastasis.
Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
[TBL] [Abstract][Full Text] [Related]
19. Bone imaging in metastatic breast cancer.
Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
Kosmin M; Padhani AR; Gogbashian A; Woolf D; Ah-See ML; Ostler P; Sutherland S; Miles D; Noble J; Koh DM; Marshall A; Dunn J; Makris A
Radiology; 2020 Dec; 297(3):622-629. PubMed ID: 33078998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]